Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function

Inflammation and Asymmetric Dimethylarginine for Predicting Death and Cardiovascular Events in ESRD Patients

(2011) G. Tripepi et al.   Clinical Journal of the American Society of Nephrology

Asymmetric Dimethylarginine and Clinical Outcomes in Chronic Kidney Disease

(2011) T.-M. Lu et al.   Clinical Journal of the American Society of Nephrology

Soluble TWEAK and PTX3 in Nondialysis CKD Patients: Impact on Endothelial Dysfunction and Cardiovascular Outcomes

(2011) M. I. Yilmaz et al.   Clinical Journal of the American Society of Nephrology

Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography

(2011) Tse-Min Lu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Peripheral Artery Disease Is Associated With a High CD163/TWEAK Plasma Ratio

(2010) Juan A. Moreno et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

TWEAK-Fn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells

(2010) B. Munoz-Garcia et al.   CARDIOVASCULAR RESEARCH

Tumor Necrosis Factor–Like Weak Inducer of Apoptosis (TWEAK) Enhances Vascular and Renal Damage Induced by Hyperlipidemic Diet in ApoE-Knockout Mice

(2009) Begoña Muñoz-García et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The CD163-expressing macrophages recognize and internalize TWEAK

(2009) Juan A. Moreno et al.   ATHEROSCLEROSIS

Soluble TWEAK Plasma Levels as a Novel Biomarker of Endothelial Function in Patients with Chronic Kidney Disease

(2009) M. I. Yilmaz et al.   Clinical Journal of the American Society of Nephrology

Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?

(2009) Mahmut Ilker Yilmaz et al.   CLINICAL TRANSPLANTATION

Considering TWEAK as a target for therapy in renal and vascular injury

(2009) Alberto Ortiz et al.   CYTOKINE & GROWTH FACTOR REVIEWS

A catalogue of reporting guidelines for health research

(2009) I. Simera et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Additive Effects of Soluble TWEAK and Inflammation on Mortality in Hemodialysis Patients

(2008) J. J. Carrero et al.   Clinical Journal of the American Society of Nephrology